RxDoctor Payments Data

Gary Hayden, PA

Physician Assistant · Shelbyville, ILNPI 1992797625

Payments from drug & device makers

$624in general payments, 2019–2025

Across 37 payments — averaging $16.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$178
  • Amgen$135
  • Lilly USA, LLC$66
  • AstraZeneca$62
  • Abbott$59
  • Kowa Pharmaceuticals America, Inc.$29
  • plus $96 from 6 others

What the payments were for

  • Food & beverage$624100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$624 in reported general payments places this provider in the 65th percentile of 3,912 physician assistant providers in Illinois.

See all physician assistant providers in Illinois

Medicare billing

Part B allowed, 2024
$42,940
Medicare patients
214
Services billed
763

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide67$71,688
EliquisApixaban66$56,884
JardianceEmpagliflozin28$23,015
Breo ElliptaFluticasone/Vilanterol36$19,189
CreonLipase/Protease/Amylase11$17,997
JanuviaSitagliptin Phosphate22$15,326
XareltoRivaroxaban18$14,036
Trelegy ElliptaFluticasone/Umeclidin/Vilanter16$13,021
FarxigaDapagliflozin Propanediol17$9,496
Spiriva HandihalerTiotropium Bromide15$8,755
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl13$7,844
JanumetSitagliptin Phos/Metformin Hcl12$6,830
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog13$5,616
DuleraMometasone/Formoterol13$4,587
Potassium Chloride133$4,430

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$178$71,68867 claims
PfizerEliquis$18$56,88466 claims
GSKBreo Ellipta, Trelegy Ellipta, Incruse Ellipta$15$35,57763 claims
AstraZenecaFarxiga$62$9,49617 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 3,912 physician assistant providers in Illinois.

Other physician assistant in Shelbyville

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →